FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/03/040896 [Registered on: 08/03/2022] Trial Registered Prospectively
Last Modified On: 07/03/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To compare analgesic effect of two different doses of intrathecal nalbuphine (0.8 mg versus 1.6mg) as an adjuvant to 0.75% isobaric ropivacaine along with control group for elective lower limb surgeries 
Scientific Title of Study   Analgesic effect of intrathecal two different doses of nalbuphine 0.8mg versus 1.6 mg as an adjuvant to 0.75% isobaric ropivacaine for elective lower limb surgeries: a randomized double blind controlled interventional study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sunita Meena 
Designation  Associate Professor 
Affiliation  Sawai Man Singh medical college and atttached hospitals 
Address  Department of Anaesthesiology,Sawai Man Singh medical college and atttached hospitals,Adarsh Nagar jaipur.

Jaipur
RAJASTHAN
302004
India 
Phone  9461290011  
Fax    
Email  sunitameena98@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sunita Meena 
Designation  Associate Professor 
Affiliation  Sawai Man Singh medical college and atttached hospitals 
Address  Department of Anaesthesiology,Sawai Man Singh medical college and atttached hospitals,Adarsh Nagar jaipur.

Jaipur
RAJASTHAN
302004
India 
Phone  9461290011  
Fax    
Email  sunitameena98@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Navdeep Chohan 
Designation  junior resident 
Affiliation  Sawai Man Singh medical college and atttached hospital 
Address  Department of Anaesthesiology,Sawai Man Singh medical college and atttached hospitals,Adarsh Nagar jaipur.

Jaipur
RAJASTHAN
302004
India 
Phone  9855213337  
Fax    
Email  navychohan15@gmail.com  
 
Source of Monetary or Material Support  
department of anaesthesiology,Sawai Man Singh medical college and atttached hospital 
 
Primary Sponsor  
Name  Sawai Man Singh medical college and atttached hospital 
Address  JLN Marg,Adarsh Nagar,Jaipur. 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Navdeep Chohan  SMS Medical college and hospital  Department of Anaesthesiology ,Dhanvantri building,1st floor,Adarsh Nagar ,jaipur
Jaipur
RAJASTHAN 
9855213337

navychohan15@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SMS Medical College and Attached Hospitals, Jaipur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M849||Disorder of continuity of bone, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  injection 0.75% isobaric ropivacaine 15mg  Intrathecal 2ml of 0 .75% isobaric ropivacaine + 0.5ml normal saline (Total volume 2.5 ml). 
Comparator Agent  injection nalbuphine 0.8mg  Intrathecal 2ml of 0.75% isobaric ropivacaine + 0.8mg nalbuphine made up to 0.5 ml volume with normal saline (Total volume 2.5 ml). 
Comparator Agent  injection nalbuphine 1.6mg  Intrathecal 2ml of 0.75% isobaric ropivacaine + 1.6 mg nalbuphine made up to 0.5 ml volume with normal saline (Total volume 2.5 ml). 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patient of either sex.
Age group between 18 to 60 years.
Weight of the patient between 40-70 kilograms.
Height of the patient ≥ 145cm.
Patients belonging to ASA class I and II.
Patients undergoing elective lower limb surgery. 
 
ExclusionCriteria 
Details  Patient’s refusal for spinal anaesthesia.
Uncooperative patients.
Patients not willing to participate in the study.
Patients with compromised airway or morbid obesity.
Patients with contraindications for spinal anesthesia.
History of convulsion, allergy to the drug used, bleeding disorder, severe neurological deficit.
Patients with history of hypertension, diabetes mallietus, respiratory, cardiac, hepatic or renal disease (necessitating classification in ASA Class III or above).
Pregnant patients.
Patient receiving phenothiazine, hypnotics or other central nervous system depressants.
•Patients in which spinal anesthesia failed. 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To access and compare the time duration for need of first rescue dose of analgesic among three groups  At every 2 minutes for initial 10 minutes, 5 minutes for 10-30 minutes then every 10 minutes till surgery ends and then every 30 minutes for 6 hours after giving subarachnoid block. 
 
Secondary Outcome  
Outcome  TimePoints 
1.To find out the difference in mean onset time & duration of sensory & motor block between the three groups.

2.To assess & compare hemodynamic parameters (heart rate, mean blood pressure, systolic blood pressure & diastolic blood pressure), sedation score and post-operative visual analogue scale score.

3.To find out & compare the proportion of cases with side effects and complications 
At every 2 minutes for initial 10 minutes, 5 minutes for 10-30 minutes then every 10 minutes till surgery ends and then every 30 minutes for 6 hours after giving subarachnoid block. 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   14/03/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   By studying and comparing the analgesic effect of above mentioned doses of intrathecal nalbuphine as an adjuvant to 0.75% isobaric ropivacaine along with control group in elective lower limb surgeries will help us to be more efficient in providing best anaesthesia possible to  the patient and open up to more research projects.  
Close